Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemin for Prevention of Post-ERCP Acute Pancreatitis
NCT01855841Phase 2Completed
- Sponsor
- Erasmus Hospital
- Start
- Apr 2012
- Primary completion
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of heme arginate in acute pancreatitis (AP), sponsored by Erasmus Hospital. Started Apr 2012; status: completed.
02
Drugs
heme arginate
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT01855841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01855841.